Joanne Sadowski Ingwall - Department of Medicine

Previous

|

|

Return to Search Results

|

Next

Joanne Sadowski Ingwall

Biochemist, Brigham and Women's Hospital
Professor of Medicine (Physiology), Emeritus, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
Cardiovascular
75 Francis Street
Boston, MA 02115

Keywords (MeSH):	Creatine Kinase Energy Metabolism Myocardial Contraction Heart Myocardium Adenosine Triphosphate

Publications (Pulled from Harvard Catalyst Profiles): 1. Taegtmeyer H, Ingwall JS. Creatine--a dispensable metabolite? Circ Res. 2013 Mar 15; 112(6):878-80. 2. Grossman AN, Opie LH, Beshansky JR, Ingwall JS, Rackley CE, Selker HP. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart. Circulation. 2013 Mar 5; 127(9):1040-8. 3. He H, Hoyer K, Tao H, Rice R, Jimenez J, Tardiff JC, Ingwall JS. Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific. J Physiol. 2012 Nov 1; 590(Pt 21):5371-88. 4. Selker HP, Beshansky JR, Griffith JL, D'Agostino RB, Massaro JM, Udelson JE, Rashba EJ, Ruthazer R, Sheehan PR, Desvigne-Nickens P, Rosenberg YD, Atkins JM, Sayah AJ, Aufderheide TP, Rackley CE, Opie LH, Lambrew CT, Cobb LA, Macleod BA, Ingwall JS, Zalenski RJ, Apstein CS. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J. 2012 Mar; 163(3):315-22. 5. Pinz I, Zhu M, Mende U, Ingwall JS. An improved isolation procedure for adult mouse cardiomyocytes. Cell Biochem Biophys. 2011 Sep; 61(1):93-101. 6. Dzeja PP, Hoyer K, Tian R, Zhang S, Nemutlu E, Spindler M, Ingwall JS. Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency. J Physiol. 2011 Nov 1; 589(Pt 21):5193-211. 7. Hoyer K, Song Y, Wang D, Phan D, Balschi J, Ingwall JS, Belardinelli L, Shryock JC. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain. J Pharmacol Exp Ther. 2011 May; 337(2):513-23. 8. Pinz I, Tian R, Belke D, Swanson E, Dillmann W, Ingwall JS. Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a. J Biol Chem. 2011 Mar 25; 286(12):10163-8. 9. Ingwall JS, Shen W. On energy circuits in the failing myocardium. Eur J Heart Fail. 2010 Dec; 12(12):1268-70. 10. Rice R, Guinto P, Dowell-Martino C, He H, Hoyer K, Krenz M, Robbins J, Ingwall JS, Tardiff JC. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts. J Mol Cell Cardiol. 2010 May; 48(5):979-88. show all 11. Shen W, Vatner DE, Vatner SF, Ingwall JS. Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha. J Mol Cell Cardiol. 2010 Apr; 48(4):591-9. 12. Ingwall JS. On the control of metabolic remodeling in mitochondria of the failing heart. Circ Heart Fail. 2009 Jul; 2(4):275-7. 13. Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, Zhang L, Pratt RE, Dzau VJ, Ingwall JS. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells. 2009 Apr; 27(4):971-9. 14. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res. 2009 Feb 15; 81(3):412-9. 15. Pinz I, Wax SD, Anderson P, Ingwall JS. Low over-expression of TNFalpha in the mouse heart increases contractile performance via TNFR1. J Cell Biochem. 2008 Sep 1; 105(1):99-107. 16. Ren J, Davidoff AJ, Ingwall JS. Creatine kinase inhibitor iodoacetamide antagonizes calcium-stimulated inotropy in cardiomyocytes. Clin Exp Pharmacol Physiol. 2009 Feb; 36(2):141-5. 17. Selker HP, Ingwall J, Rackley CE. Glucose-insulin-potassium therapy in patients with STEMI. JAMA. 2008 May 28; 299(20):2385; author reply 2387-8. 18. Tian R, Ingwall JS. How does folic acid cure heart attacks? Circulation. 2008 Apr 8; 117(14):1772-4. 19. Pinz I, Ostroy SE, Hoyer K, Osinska H, Robbins J, Molkentin JD, Ingwall JS. Calcineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol. 2008 Mar; 294(3):H1459-66. 20. Ingwall JS. On substrate selection for ATP synthesis in the failing human myocardium. Am J Physiol Heart Circ Physiol. 2007 Dec; 293(6):H3225-6. 21. Pinz I, Robbins J, Rajasekaran NS, Benjamin IJ, Ingwall JS. Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts. FASEB J. 2008 Jan; 22(1):84-92. 22. He H, Javadpour MM, Latif F, Tardiff JC, Ingwall JS. R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J. 2007 Sep 1; 93(5):1834-44. 23. Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J Clin Invest. 2007 May; 117(5):1432-9. 24. Ingwall JS. On the hypothesis that the failing heart is energy starved: lessons learned from the metabolism of ATP and creatine. Curr Hypertens Rep. 2006 Dec; 8(6):457-64. 25. Hoyer K, Krenz M, Robbins J, Ingwall JS. Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency. J Mol Cell Cardiol. 2007 Jan; 42(1):214-21. 26. Ingwall JS. Energetics of the failing heart: new insights using genetic modification in the mouse. Arch Mal Coeur Vaiss. 2006 Sep; 99(9):839-47. 27. Ingwall JS, Balschi JA. Energetics of the Na(+) pump in the heart. J Cardiovasc Electrophysiol. 2006 May; 17 Suppl 1:S127-S133. 28. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006 Apr; 20(6):661-9. 29. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, La Cross NC, D'Alecy LG, Ingwall JS, Metzger JM. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med. 2006 Feb; 12(2):181-9. 30. Ertz-Berger BR, He H, Dowell C, Factor SM, Haim TE, Nunez S, Schwartz SD, Ingwall JS, Tardiff JC. Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18219-24. 31. Ahmad F, Arad M, Musi N, He H, Wolf C, Branco D, Perez-Atayde AR, Stapleton D, Bali D, Xing Y, Tian R, Goodyear LJ, Berul CI, Ingwall JS, Seidman CE, Seidman JG. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Circulation. 2005 Nov 15; 112(20):3140-8. 32. Shen W, Spindler M, Higgins MA, Jin N, Gill RM, Bloem LJ, Ryan TP, Ingwall JS. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system. J Mol Cell Cardiol. 2005 Sep; 39(3):537-44. 33. Zou L, Shen M, Arad M, He H, Løfgren B, Ingwall JS, Seidman CE, Seidman JG, Tian R. N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity. Circ Res. 2005 Aug 19; 97(4):323-8. 34. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005 Apr; 1(4):259-71. 35. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005 Apr; 11(4):367-8. 36. Nascimben L, Ingwall JS, Lorell BH, Pinz I, Schultz V, Tornheim K, Tian R. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension. 2004 Nov; 44(5):662-7. 37. Ingwall JS. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol. 2004 Sep; 37(3):613-23. 38. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004 Jul 23; 95(2):135-45. 39. Ingwall JS. Do the FHC-associated R403 mutations in myosin heavy chain lead to a greater energetic cost of contraction? J Mol Cell Cardiol. 2004 Mar; 36(3):327-30. 40. Javadpour MM, Tardiff JC, Pinz I, Ingwall JS. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest. 2003 Sep; 112(5):768-75. 41. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003 Sep; 9(9):1195-201. 42. Bak MI, Ingwall JS. Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart. Cardiovasc Res. 2003 Mar 15; 57(4):1004-14. 43. Ingwall JS. Is creatine kinase a target for AMP-activated protein kinase in the heart? J Mol Cell Cardiol. 2002 Sep; 34(9):1111-20. 44. Marston SB, Ingwall JS, Glueck SB. Calcium, contractions, and tropomyosin Focus on "divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins". Physiol Genomics. 2002; 9(2):57-8. 45. Shen W, Tian R, Saupe KW, Spindler M, Ingwall JS. Endogenous nitric oxide enhances coupling between O2 consumption and ATP synthesis in guinea pig hearts. Am J Physiol Heart Circ Physiol. 2001 Aug; 281(2):H838-46. 46. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001 Jul 20; 89(2):168-73. 47. Saupe KW, Eberli FR, Ingwall JS, Apstein CS. Metabolic support as an adjunct to inotropic support in the hypoperfused heart. J Mol Cell Cardiol. 2001 Feb; 33(2):261-9. 48. Pachucki J, Hopkins J, Peeters R, Tu H, Carvalho SD, Kaulbach H, Abel ED, Wondisford FE, Ingwall JS, Larsen PR. Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology. 2001 Jan; 142(1):13-20. 49. O'Brien SE, Apkon M, Berul CI, Patel HT, Saupe K, Spindler M, Ingwall JS, Zahler R. Phenotypical features of long Q-T syndrome in transgenic mice expressing human Na-K-ATPase alpha(3)-isoform in hearts. Am J Physiol Heart Circ Physiol. 2000 Nov; 279(5):H2133-42. 50. Saupe KW, Spindler M, Hopkins JC, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem. 2000 Jun 30; 275(26):19742-6. 51. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000 May 2; 101(17):2090-6. 52. Saupe KW, Lim CC, Ingwall JS, Apstein CS, Eberli FR. Comparison of hearts with 2 types of pressure-overload left ventricular hypertrophy. Hypertension. 2000 May; 35(5):1167-72. 53. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest. 1999 Dec; 104(12):1703-14. 54. Spindler M, Saupe KW, Tian R, Ahmed S, Matlib MA, Ingwall JS. Altered creatine kinase enzyme kinetics in diabetic cardiomyopathy. A(31)P NMR magnetization transfer study of the intact beating rat heart. J Mol Cell Cardiol. 1999 Dec; 31(12):2175-89. 55. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation. 1999 Nov 16; 100(20):2113-8. 56. Tian R, Miao W, Spindler M, Javadpour MM, McKinney R, Bowman JC, Buttrick PM, Ingwall JS. Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery. Proc Natl Acad Sci U S A. 1999 Nov 9; 96(23):13536-41. 57. Saupe KW, Eberli FR, Ingwall JS, Apstein CS. Hypoperfusion-induced contractile failure does not require changes in cardiac energetics. Am J Physiol. 1999 May; 276(5 Pt 2):H1715-23. 58. Tian R, Halow JM, Meyer M, Dillmann WH, Figueredo VM, Ingwall JS, Camacho SA. Thermodynamic limitation for Ca2+ handling contributes to decreased contractile reserve in rat hearts. Am J Physiol. 1998 Dec; 275(6 Pt 2):H2064-71. 59. Ingwall JS, Kelly RA. Nitric oxide, myocardial oxygen consumption, and ATP synthesis. Circ Res. 1998 Nov 16; 83(10):1067-8. 60. Clarke K, Cross HR, Keon CA, Radda GK, Ingwall JS. Cation MR spectroscopy (7Li, 23Na, 39K and 87Rb). MAGMA. 1998 Sep; 6(2-3):105-6. 61. Spindler M, Saupe KW, Ingwall JS. MR spectroscopy of transgenic mice. MAGMA. 1998 Sep; 6(2-3):109-10. 62. Ingwall JS. Creatine kinase knockout mice--what is the phenotype: heart. MAGMA. 1998 Sep; 6(2-3):120-1. 63. Cittadini A, Ishiguro Y, Strömer H, Spindler M, Moses AC, Clark R, Douglas PS, Ingwall JS, Morgan JP. Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res. 1998 Jul 13; 83(1):50-9. 64. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res. 1998 May 4; 82(8):898-907. 65. Spindler M, Saupe KW, Christe ME, Sweeney HL, Seidman CE, Seidman JG, Ingwall JS. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest. 1998 Apr 15; 101(8):1775-83. 66. Bak MI, Ingwall JS. Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow. Am J Physiol. 1998 Apr; 274(4 Pt 1):C992-1001. 67. Bak MI, Wei JY, Ingwall JS. Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol. 1998 Mar; 30(3):661-72. 68. Mann DV, Robinson MK, Rounds JD, DeRosa E, Niles DA, Ingwall JS, Wilmore DW, Jacobs DO. Superiority of blood over saline resuscitation from hemorrhagic shock: a 31P magnetic resonance spectroscopy study. Ann Surg. 1997 Nov; 226(5):653-61. 69. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997 Oct 7; 96(7):2190-6. 70. Tian R, Nascimben L, Ingwall JS, Lorell BH. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation. 1997 Aug 19; 96(4):1313-9. 71. Tian R, Christe ME, Spindler M, Hopkins JC, Halow JM, Camacho SA, Ingwall JS. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest. 1997 Feb 15; 99(4):745-51. 72. Spencer RG, Buttrick PM, Ingwall JS. Function and bioenergetics in isolated perfused trained rat hearts. Am J Physiol. 1997 Jan; 272(1 Pt 2):H409-17. 73. Chu G, Luo W, Slack JP, Tilgmann C, Sweet WE, Spindler M, Saupe KW, Boivin GP, Moravec CS, Matlib MA, Grupp IL, Ingwall JS, Kranias EG. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res. 1996 Dec; 79(6):1064-76. 74. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996 Oct 15; 94(8):1894-901. 75. Laser A, Ingwall JS, Tian R, Reis I, Hu K, Gaudron P, Ertl G, Neubauer S. Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction. J Mol Cell Cardiol. 1996 Jul; 28(7):1531-8. 76. Gross WL, Bak MI, Ingwall JS, Arstall MA, Smith TW, Balligand JL, Kelly RA. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5604-9. 77. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996 May 3; 272(5262):731-4. 78. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res. 1996 May; 78(5):893-902. 79. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996 Apr; 28(4):755-65. 80. Tian R, Ingwall JS. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol. 1996 Apr; 270(4 Pt 2):H1207-16. 81. Laser A, Neubauer S, Tian R, Hu K, Gaudron P, Ingwall JS, Ertl G. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. J Am Coll Cardiol. 1996 Feb; 27(2):487-93. 82. Friedrich J, Apstein CS, Ingwall JS. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart. Circulation. 1995 Dec 15; 92(12):3527-38. 83. Hamman BL, Bittl JA, Jacobus WE, Allen PD, Spencer RS, Tian R, Ingwall JS. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am J Physiol. 1995 Sep; 269(3 Pt 2):H1030-6. 84. Gwathmey JK, Liao R, Ingwall JS. Comparison of twitch force and calcium handling in papillary muscles from right ventricular pressure overload hypertrophy in weanling and juvenile ferrets. Cardiovasc Res. 1995 Apr; 29(4):475-81. 85. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation. 1995 Mar 15; 91(6):1824-33. 86. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS, et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995 Mar; 95(3):1092-100. 87. Ingwall JS. How high does intracellular sodium rise during acute myocardial ischaemia? A view from NMR spectroscopy. Cardiovasc Res. 1995 Feb; 29(2):279. 88. Stewart LC, Kelly RA, Atkinson DE, Ingwall JS. pH heterogeneity in aged hypertensive rat hearts distinguishes reperfused from persistently ischemic myocardium. J Mol Cell Cardiol. 1995 Jan; 27(1):321-33. 89. Hajjar RJ, Ingwall JS, Gwathmey JK. Mechanism of action of 2,3-butanedione monoxime on contracture during metabolic inhibition. Am J Physiol. 1994 Jul; 267(1 Pt 2):H100-8. 90. Bak MI, Ingwall JS. Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5'-nucleotidase. J Clin Invest. 1994 Jan; 93(1):40-9. 91. Stewart L, Hamilton C, Ingwall J, Naomi S, Graves S, Canessa M, Williams G, Hollenberg N. Vascular smooth muscle response to ouabain. Relation of tissue Na+ to the contractile response. Circ Res. 1993 Dec; 73(6):1113-20. 92. Glass MG, Fuleihan F, Liao R, Lincoff AM, Chapados R, Hamlin R, Apstein CS, Allen PD, Ingwall JS, Hajjar RJ, et al. Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force. Circ Res. 1993 Dec; 73(6):1077-89. 93. Clarke K, Stewart LC, Neubauer S, Balschi JA, Smith TW, Ingwall JS, Nédélec JF, Humphrey SM, Kléber AG, Springer CS. Extracellular volume and transsarcolemmal proton movement during ischemia and reperfusion: a 31P NMR spectroscopic study of the isovolumic rat heart. NMR Biomed. 1993 Jul-Aug; 6(4):278-86. 94. Friedrich J, Nascimben L, Liao R, Ingwall JS. Phosphocreatine T1 measurements with and without exchange in the heart. Magn Reson Med. 1993 Jul; 30(1):45-50. 95. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol. 1992 Nov; 263(5 Pt 2):H1576-86. 96. Neubauer S, Newell JB, Ingwall JS. Metabolic consequences and predictability of ventricular fibrillation in hypoxia. A 31P- and 23Na-nuclear magnetic resonance study of the isolated rat heart. Circulation. 1992 Jul; 86(1):302-10. 97. Bak MI, Ingwall JS. NMR-invisible ATP in heart: fact or fiction? Am J Physiol. 1992 Jun; 262(6 Pt 1):E943-7. 98. Zahler R, Ingwall JS. Estimation of heart mitochondrial creatine kinase flux using magnetization transfer NMR spectroscopy. Am J Physiol. 1992 Apr; 262(4 Pt 2):H1022-8. 99. Ingwall JS. Whole-organ enzymology of the creatine kinase system in heart. Biochem Soc Trans. 1991 Nov; 19(4):1006-10. 100. Neubauer S, Ingwall JS. The isolated, buffer-perfused ferret heart: a new model for the study of cardiac physiology and metabolism. Lab Anim. 1991 Oct; 25(4):348-53. 101. McAuliffe JJ, Perry SB, Brooks EE, Ingwall JS. Kinetics of the creatine kinase reaction in neonatal rabbit heart: an empirical analysis of the rate equation. Biochemistry. 1991 Mar 12; 30(10):2585-93. 102. Kohler SJ, Perry SB, Stewart LC, Atkinson DE, Clarke K, Ingwall JS. Analysis of 23Na NMR spectra from isolated perfused hearts. Magn Reson Med. 1991 Mar; 18(1):15-27. 103. Smith SH, Kramer MF, Reis I, Bishop SP, Ingwall JS. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res. 1990 Dec; 67(6):1334-44. 104. Balschi JA, Bittl JA, Springer CS, Ingwall JS. 31P and 23Na NMR spectroscopy of normal and ischemic rat skeletal muscle. Use of a shift reagent in vivo. NMR Biomed. 1990 Apr; 3(2):47-58. 105. Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J. 1990 Apr; 11 Suppl B:108-15. 106. Neubauer S, Ingwall JS. Verapamil attenuates ATP depletion during hypoxia: 31P NMR studies of the isolated rat heart. J Mol Cell Cardiol. 1989 Nov; 21(11):1163-78. 107. McAuliffe JJ, Perry SB, Brooks EE, Ingwall JS. The kinetics of the creatine kinase reaction in neonatal rabbit heart: does the rate equation accurately describe the kinetics observed in the isolated perfused heart? Prog Clin Biol Res. 1989; 315:581-92. 108. Spencer RG, Balschi JA, Leigh JS, Ingwall JS. ATP synthesis and degradation rates in the perfused rat heart. 31P-nuclear magnetic resonance double saturation transfer measurements. Biophys J. 1988 Nov; 54(5):921-9. 109. Neubauer S, Hamman BL, Perry SB, Bittl JA, Ingwall JS. Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31P-NMR magnetization transfer study of the isolated ferret heart. Circ Res. 1988 Jul; 63(1):1-15. 110. Wexler LF, Lorell BH, Momomura S, Weinberg EO, Ingwall JS, Apstein CS. Enhanced sensitivity to hypoxia-induced diastolic dysfunction in pressure-overload left ventricular hypertrophy in the rat: role of high-energy phosphate depletion. Circ Res. 1988 Apr; 62(4):766-75. 111. Perry SB, McAuliffe J, Balschi JA, Hickey PR, Ingwall JS. Velocity of the creatine kinase reaction in the neonatal rabbit heart: role of mitochondrial creatine kinase. Biochemistry. 1988 Mar 22; 27(6):2165-72. 112. Ingwall JS. ATP utilization and ATP synthesis. J Mol Cell Cardiol. 1987 Dec; 19(12):1149-52. 113. Bittl JA, DeLayre J, Ingwall JS. Rate equation for creatine kinase predicts the in vivo reaction velocity: 31P NMR surface coil studies in brain, heart, and skeletal muscle of the living rat. Biochemistry. 1987 Sep 22; 26(19):6083-90. 114. Halperin JA, Brugnara C, Kopin AS, Ingwall J, Tosteson DC. Properties of the Na+-K+ pump in human red cells with increased number of pump sites. J Clin Invest. 1987 Jul; 80(1):128-37. 115. Hitzig BM, Prichard JW, Kantor HL, Ellington WR, Ingwall JS, Burt CT, Helman SI, Koutcher J. NMR spectroscopy as an investigative technique in physiology. FASEB J. 1987 Jul; 1(1):22-31. 116. Zahler R, Bittl JA, Ingwall JS. Analysis of compartmentation of ATP in skeletal and cardiac muscle using 31P nuclear magnetic resonance saturation transfer. Biophys J. 1987 Jun; 51(6):883-93. 117. Bittl JA, Balschi JA, Ingwall JS. Effects of norepinephrine infusion on myocardial high-energy phosphate content and turnover in the living rat. J Clin Invest. 1987 Jun; 79(6):1852-9. 118. Bittl JA, Balschi JA, Ingwall JS. Contractile failure and high-energy phosphate turnover during hypoxia: 31P-NMR surface coil studies in living rat. Circ Res. 1987 Jun; 60(6):871-8. 119. Brooks WW, Ingwall JS, Conrad CH, Holubarsch C, Bing OH. Tolerance to hypoxia of myocardium from adult and aged spontaneously hypertensive rats. Am J Physiol. 1987 Jun; 252(6 Pt 2):H1096-104. 120. Grossman W, Momomura SI, Ingwall JS. Diastolic relaxation abnormalities during ischaemia and their association with high energy phosphate depletion, intracellular pH and myocardial blood flow. Basic Res Cardiol. 1987; 82 Suppl 2:289-99. 121. Ingwall JS, Bittl JA. Regulation of heart creatine kinase. Basic Res Cardiol. 1987; 82 Suppl 2:93-101. 122. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation. 1987 Jan; 75(1 Pt 2):I96-101. 123. Wexler LF, Weinberg EO, Ingwall JS, Apstein CS. Acute alterations in diastolic left ventricular chamber distensibility: mechanistic differences between hypoxemia and ischemia in isolated perfused rabbit and rat hearts. Circ Res. 1986 Nov; 59(5):515-28. 124. Neill WA, Ingwall JS. Stabilization of a derangement in adenosine triphosphate metabolism during sustained, partial ischemia in the dog heart. J Am Coll Cardiol. 1986 Oct; 8(4):894-900. 125. Bittl JA, Ingwall JS. The energetics of myocardial stretch. Creatine kinase flux and oxygen consumption in the noncontracting rat heart. Circ Res. 1986 Mar; 58(3):378-83. 126. Momomura S, Ingwall JS, Parker JA, Sahagian P, Ferguson JJ, Grossman W. The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium. Circ Res. 1985 Dec; 57(6):822-35. 127. Springer CS, Pike MM, Balschi JA, Chu SC, Frazier JC, Ingwall JS, Smith TW. Use of shift reagents for nuclear magnetic resonance studies of the kinetics of ion transfer in cells and perfused hearts. Circulation. 1985 Nov; 72(5 Pt 2):IV89-93. 128. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985 Oct 24; 313(17):1050-4. 129. Hale SL, Alker KJ, Lo HM, Ingwall JS, Kloner RA. Alterations in the distribution of high-energy phosphates during ischemia in a canine model of reperfusion-induced ventricular fibrillation. Am Heart J. 1985 Sep; 110(3):590-4. 130. Pike MM, Frazer JC, Dedrick DF, Ingwall JS, Allen PD, Springer CS, Smith TW. 23Na and 39K nuclear magnetic resonance studies of perfused rat hearts. Discrimination of intra- and extracellular ions using a shift reagent. Biophys J. 1985 Jul; 48(1):159-73. 131. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem. 1985 Mar 25; 260(6):3512-7. 132. Ingwall JS. The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Heart J. 1984 Dec; 5 Suppl F:129-39. 133. Lange R, Ingwall J, Hale SL, Alker KJ, Braunwald E, Kloner RA. Preservation of high-energy phosphates by verapamil in reperfused myocardium. Circulation. 1984 Oct; 70(4):734-41. 134. Lange R, Ingwall JS, Hale SL, Alker KJ, Kloner RA. Effects of recurrent ischemia on myocardial high energy phosphate content in canine hearts. Basic Res Cardiol. 1984 Jul-Aug; 79(4):469-78. 135. Conrad CH, Brooks WW, Ingwall JS, Bing OH. Inhibition of hypoxic myocardial contracture by Cobalt in the rat. J Mol Cell Cardiol. 1984 Apr; 16(4):345-54. 136. Vatner DE, Ingwall JS. Effects of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes. Proc Soc Exp Biol Med. 1984 Jan; 175(1):5-9. 137. DeBoer LW, Rude RE, Kloner RA, Ingwall JS, Maroko PR, Davis MA, Braunwald E. A flow- and time-dependent index of ischemic injury after experimental coronary occlusion and reperfusion. Proc Natl Acad Sci U S A. 1983 Sep; 80(18):5784-8. 138. Pernot AC, Ingwall JS, Menasche P, Grousset C, Bercot M, Piwnica A, Fossel ET. Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: a phosphorus-31 nuclear magnetic resonance study. Circulation. 1983 Jun; 67(6):1296-303. 139. Goldhaber SZ, Newell JB, Alpert NM, Andrews E, Pohost GM, Ingwall JS. Effects of ischemic-like insult on myocardial thallium-201 accumulation. Circulation. 1983 Apr; 67(4):778-86. 140. Goldhaber SZ, Newell JB, Ingwall JS, Pohost GM, Alpert NM, Fossel ET. Effects of reduced coronary flow on thallium-201 accumulation and release in an in vitro rat heart preparation. Am J Cardiol. 1983 Mar 1; 51(5):891-6. 141. Ouellette AJ, Watson RK, Billmire K, Dygert MK, Ingwall JS. Protein synthesis in the cultured fetal mouse heart: effects of deprivation of oxygen and oxidizable substrate. Biochemistry. 1983 Mar 1; 22(5):1201-7. 142. Norwood WI, Ingwall JS, Norwood CR, Fossel ET. Developmental changes of creatine kinase metabolism in rat brain. Am J Physiol. 1983 Mar; 244(3):C205-10. 143. Ouellette AJ, Croall DE, Van Ness J, Ingwall JS. Developmental regulation of mRNA in mouse heart. Proc Natl Acad Sci U S A. 1983 Jan; 80(1):223-7. 144. Goldhaber SZ, Pohost GM, Kloner RA, Andrews E, Newell JB, Ingwall JS. Inosine: a protective agent in an organ culture model of myocardial ischemia. Circ Res. 1982 Aug; 51(2):181-8. 145. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol. 1982 May; 242(5):H729-44. 146. Pernot AC, Ingwall JS, Menasche P, Grousset C, Bercot M, Mollet M, Piwnica A, Fossel ET. Limitations of potassium cardioplegia during cardiac ischemic arrest: a phosphorus 31 nuclear magnetic resonance study. Ann Thorac Surg. 1981 Dec; 32(6):536-45. 147. Kloner RA, DeBoer LW, Darsee JR, Ingwall JS, Braunwald E. Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion. Proc Natl Acad Sci U S A. 1981 Nov; 78(11):7152-6. 148. Kloner RA, DeBoer LW, Darsee JR, Ingwall JS, Hale S, Tumas J, Braunwald E. Prolonged abnormalities of myocardium salvaged by reperfusion. Am J Physiol. 1981 Oct; 241(4):H591-9. 149. Ingwall JS, Kramer MF, Woodman D, Friedman WF. Maturation of energy metabolism in the lamb: changes in myosin ATPase and creatine kinase activities. Pediatr Res. 1981 Aug; 15(8):1128-33. 150. DeLayre JL, Ingwall JS, Malloy C, Fossel ET. Gated sodium-23 nuclear magnetic resonance images of an isolated perfused working rat heart. Science. 1981 May 22; 212(4497):935-6. 151. Menasché P, Piwnica A, Ingwall JS, Fossel ET. [A new method to evaluate myocardial preservation techniques (author's transl)]. Nouv Presse Med. 1981 Feb 7; 10(5):295-8. 152. Braunwald E, DeBoer LW, Glogar DH, Darsee JR, Ertl G, Ingwall JS, Kloner RA. Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia. Acta Med Scand Suppl. 1981; 651:123-32. 153. Goldman MR, Pohost GM, Ingwall JS, Fossel ET. Nuclear magnetic resonance imaging: potential cardiac applications. Am J Cardiol. 1980 Dec 18; 46(7):1278-83. 154. DeBoer LW, Ingwall JS, Kloner RA, Braunwald E. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5471-5. 155. Kloner RA, Ingwall JS. The cultured fetal mouse heart as a model for studying myocardial ischemic necrosis. Exp Mol Pathol. 1980 Jun; 32(3):317-35. 156. Fossel ET, Morgan HE, Ingwall JS. Measurement of changes in high-energy phosphates in the cardiac cycle using gated 31P nuclear magnetic renonance. Proc Natl Acad Sci U S A. 1980 Jun; 77(6):3654-8. 157. Elson HF, Ingwall JS. The cell substratum modulates skeletal muscle differentiation. J Supramol Struct. 1980; 14(3):313-28. 158. Pohost GM, Alpert NM, Ingwall JS, Strauss HW. Thallium redistribution: mechanisms and clinical utility. Semin Nucl Med. 1980 Jan; 10(1):70-93. 159. Ingwall JS, Roeske WR, Wildenthal K. The fetal mouse heart in organ culture: maintenance of the differentiated state. Methods Cell Biol. 1980; 21A:167-86. 160. Norwood WI, Norwood CR, Ingwall JS, Castaneda AR, Fossel ET. Hypothermic circulatory arrest: 31-phosphorus nuclear magnetic resonsance of isolated perfused neonatal rat brain. J Thorac Cardiovasc Surg. 1979 Dec; 78(6):823-30. 161. Libby P, Ingwall JS, Goldberg AL. Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin. Am J Physiol. 1979 Jul; 237(1):E35-9. 162. Sybers HD, Ingwall J, DeLuca M. Autophagic response to sublethal injury in cardiac myocytes. J Mol Cell Cardiol. 1979 Apr; 11(4):331-8. 163. Roeske WR, Deluca M, Ingwall JS. Factors influencing enzyme release from cultured fetal mouse hearts deprived of oxygen and glucose. J Mol Cell Cardiol. 1978 Oct; 10(10):907-19. 164. Kaufman IA, Hall NF, DeLuca MA, Ingwall JS, Mayer SE. Metabolism of adenine nucleotides in the cultured fetal mouse heart. Am J Physiol. 1977 Aug; 233(2):H282-8. 165. Roeske WR, Ingwall JS, DeLuca M, Sybers HD. Thermally induced myocardial preservation and necrosis in deprived fetal mouse hearts. Am J Physiol. 1977 Mar; 232(3):H288-96. 166. Schelbert HR, Ingwall JS, Sybers HD, Ashburn WL. Uptake of infarct-imaging agents in reversibly and irreversibly injured myocardium in cultured fetal mouse heart. Circ Res. 1976 Dec; 39(6):860-8. 167. Wildenthal K, Griffin EE, Ingwall JS. Hormonal control of cardiac protein and amino acid balance. Circ Res. 1976 May; 38(5 Suppl 1):I138-44. 168. Ingwall JS. Creatine and the control of muscle-specific protein synthesis in cardiac and skeletal muscle. Circ Res. 1976 May; 38(5 Suppl 1):I115-23. 169. Ingwall JS, Wildential K. Fetal mouse hearts in organ culture. Studies in cardiac metabolism. Recent Adv Stud Cardiac Struct Metab. 1976 May 26-29; 12:621-33. 170. Sybers HD, Ingwall J, DeLuca M. Autophagy in cardiac myocytes. Recent Adv Stud Cardiac Struct Metab. 1976 May 26-29; 12:453-63. 171. Ingwall JS, Wildenthal K. Role of creatine in the regulation of cardiac protein synthesis. J Cell Biol. 1976 Jan; 68(1):159-63. 172. Ingwall JS, DeLuca M, Sybers HD, Wildenthal K. Fetal mouse hearts: a model for studying ischemia. Proc Natl Acad Sci U S A. 1975 Jul; 72(7):2809-13. 173. Sybers HD, Ingwall JS, De Luca MA. Fetal mouse heart in organ structure: ultrastructure. Lab Invest. 1975 Jun; 32(6):713-9. 174. Ingwall JS, Morales MF, Stockdale FE, Wildenthal K. Creatine: a possible stimulus skeletal cardiac muscle hypertrophy. Recent Adv Stud Cardiac Struct Metab. 1975; 8:467-81. 175. DeLuca MA, Ingwall JS, Bittl JA. Biochemical responses of myocardial cells in culture to oxygen and glucose deprivation. Biochem Biophys Res Commun. 1974 Jul 24; 59(2):749-56. 176. Ingwall JS, Weiner CD, Morales MF, Davis E, Stockdale FE. Specificity of creatine in the control of muscle protein synthesis. J Cell Biol. 1974 Jul; 62(1):145-51. 177. Ingwall JS, Morales MF, Stockdale FE. Creatine and the control of myosin synthesis in differentiating skeletal muscle. Proc Natl Acad Sci U S A. 1972 Aug; 69(8):2250-3. 178. Ingwall JS. Circular dichroism of nucleosides. I. Anomeric pairs of the D-pentofuranosides of adenine. J Am Chem Soc. 1972 Jul 26; 94(15):5487-95. 179. Ingwall JS, Scheraga HA. Purification and properties of bovine prothrombin. Biochemistry. 1969 May; 8(5):1860-9.

Send Feedback to the BWH Biomedical Research Institute.

Quick Links

EDIT YOUR PROFILE

Department

View all Research Faculty in the Department of Medicine

Division

View all Research Faculty: Cardiovascular